Roka Bioscience (ROKA) Reports Q2 Loss of $0.43

Roka Bioscience (NASDAQ: ROKA) reported Q2 EPS of ($0.43), versus ($0.54) reported last year. Revenue for the quarter came in at $1.82 million, versus $1.47 million reported last year.

For earnings history and earnings-related data on Roka Bioscience (ROKA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
• Is the global equity rally broadening? UBS weighs in